Virttu Biologics appoints Deirdre Gillespie as incoming CEO
– UK, Glasgow – Virttu Biologics, a clinical stage biotechnology company pioneering the discovery and development of unique oncolytic immunotherapies for systemic and intra-tumoural delivery treatment of cancer, today announced that Deirdre Y.…